A carregar...
Early tumor shrinkage identifies long-term disease control and survival in patients with lung cancer treated with atezolizumab
BACKGROUND: Preliminary evidence indicates that early tumor shrinkage (ETS) following immune checkpoint inhibitor (ICI) initiation may be associated with survival outcomes in patients with advanced melanoma. ETS has not been explored as a biomarker of survival outcomes or patient-reported outcomes i...
Na minha lista:
| Publicado no: | J Immunother Cancer |
|---|---|
| Main Authors: | , , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
BMJ Publishing Group
2020
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7279663/ https://ncbi.nlm.nih.gov/pubmed/32503948 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1136/jitc-2019-000500 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|